Mandy Sze-Man Lai

Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients

V. Wong, G. Wong, Bosco Ma, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

V. Wong, G. Wong, T. Yip, 2022, JAMA network open.

Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss.

V. Wong, G. Wong, H. Chan, 2022, Journal of hepatology.

Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study

V. Wong, S. Chan, G. Wong, 2023, Alimentary pharmacology & therapeutics.

Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes

V. Wong, E. Hui, G. Wong, 2023, JAMA network open.